Codes ATC:
L01BB05
Indication
Chronic lymphocytic leukaemia or small lymphocytic lymphoma
Code ICD11:
2B52.0
INN
Fludarabine
Type de médicament
Chemical agent
Type de liste
Liste complémentaire
Formulations
Parenteral > General injections > IV:
50 mg in vial (fludarabine phosphate) powder for injection
Oral > Solid: 10 mg tablet (fludarabine phosphate)
Oral > Solid: 10 mg tablet (fludarabine phosphate)
Historique des statuts LME
Ajouté pour la première fois en 2015
(TRS
994)
Sexe
Tous
Âge
Adolescents et adultes
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Résumé des preuves et recommandation du comité d'experts
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, fludarabine was added to the complementary list of the EML for use in treatment protocols for chronic lymphocytic leukaemia. The relevant extract from TRS994 regarding the Expert Committee's 2015 consideration of treatment protocols for chronic lymphocytic leukaemia is attached.